Niklas Hartung

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Atomic Force Microscopy

Epidermal Growth Factor Receptor

Chemotherapy Induced

Top Venues

CPT: pharmacometrics & systems pharmacology

PLoS computational biology

Clinical endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients. CPT: pharmacometrics & systems pharmacology (2023)
Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients. CPT: pharmacometrics & systems pharmacology (2023)
Yomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, Kimberly Geiger, Wilhelm Huisinga, Niklas Hartung, Robin Michelet, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework. Cancers 15 (22) (2023)
Niklas Hartung, Jens Markus Borghardt
A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs. PLoS computational biology 16 (12) (2020)
Johanna Melin, Niklas Hartung, Zinnia P Parra-Guillen, Martin J Whitaker, Richard J Ross, Charlotte Kloft
The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing. Clinical endocrinology 91 (1) (2019)